Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Unknown 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 79Sarcoma 4Endocrine 4Other neoplasm 3NET 3Thoracic 2CNS 2Tumor-Agnostic 1Head & Neck 1Breast 1

Conditions

Rectal Neuroendocrine Tumors 2Pituitary Neoplasms 1Neuroendocrine Tumors 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Endoscopic Mucosal Resection × Endocrine × Clear all
NCT07612748 2026-06-03

Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms

Jilin University

Phase NA Recruiting
483 enrolled
EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

NCT07373015 2026-01-28

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase NA Not yet recruiting
118 enrolled
EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

NCT06121752 2024-10-15

DNET

Asian Institute of Gastroenterology, India

Phase NA Unknown
54 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03515603 2023-05-17

Endocrine Outcome of Surgery for Pituitary Adenoma

University of Ulm

Phase NA Terminated
36 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡